Company Releases

Company Releases

Company Releases

Avita Medical Official Press Releases

March 2016

Avita Medical Announces Positive Results from Randomized, Multicentre EU Study of ReGenerCell™ for Treatment of Chronic Venous Leg Ulcers

Avita Medial Launches Expanded Regenerative Product Range in Europe

January 2016

Avita Medical CEO Shareholder Update

Avita Medical CEO Long Term Incentive Plan

Avita Medical Appoints Distributors in Japan and South Korea

Avita Medical Transforms Board with Three New Appointments

Avita Medical Completes Patient Recruitment for its FDA Approval Study Evaluating Use of ReCell® in Acute Burns

December 2015

Avita Medical Sells Respiratory Business for $2.64m

FDA Grants ReCell® EAP Designation

Avita Highlights 63 Percent Decreased Length of Hospital Stay for Patients with Large Burns Treated with ReCell

November 2015

Avita Medical 2015 AGM Updated Corporate Video

Avita Medical Expands Wound Care Market with Distributors in France and UK

Avita Medical Ltd Receives Australian Patent

Avita Medical to Present at ARM’s EU Advanced Therapies Investor Day

October 2015

Financial Results and Corporate Update First Quarter 2016

Avita Medical Presents Research Demonstrating Treatment Power of ReCell in Burns

Avita Medical Announces First Patient Treated in US Military Wound Trial

Avita Medical Highlights ReCell Findings Published in Journal of Cranio-Maxillo-Facial Surgery

Avita Announces AUD$10M Equity Financing

Avita Medical Provides Update on ReCell® Success in Treating Burn Victims in Taiwan

Avita Medical Gains CE Mark for ReGenerCell® and ReNovaCell® to Complete Skin Healing Portfolio

Avita Medical to Present at Stem Cell Meeting on the Mesa

US FDA Doubles Patient Numbers Permitted for Compassionate Use of Recell

September 2015

Avita Medical Awarded US Government Contract Valued at up to $53.9m USD

August 2015

Avita Patent Validated in Eleven European Countries

Avita Medical BARDA Proposal Achieves High Rating

AVH – Avita Medical Announces Univ of Huddersfield Research Partnership

July 2015

AVH – Avita provides humanitarian assistance and support to Taiwan 

AVH – Avita’s ReCell featured in US Army Technology Magazine 

AVH – ReCell demonstrates 78% Repigmentation Compared to control July 2015

May 2015

AVH – New U.S. Patent for ReCell

AVH – ReCell featured at important US Government Symposium

April 2015

AVH – Appointment of Adam Kelliher as Chief Executive Officer

AVH – Avita Hosts International Skin Regeneration Symposium

January 2015

AVH – Avita_First Patient Enrolment in US Pivotal Burns Study

November 2014

AVH – ASX announcement Lodged – Avita Medical Announces Receipt of $1.4 Million R&D Tax Incentive

AVH – Avita Medical Provides NICE Guidance Recommendation Update